Jin Medical International Ltd.

NasdaqCM:ZJYL Stock Report

Market Cap: US$158.1m

Jin Medical International Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Erqi Wang

Chief executive officer

US$126.4k

Total compensation

CEO salary percentage100.0%
CEO tenure4.8yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure2.9yrs

Recent management updates

Recent updates

Jin Medical International Ltd.'s (NASDAQ:ZJYL) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Oct 30
Jin Medical International Ltd.'s (NASDAQ:ZJYL) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Some Confidence Is Lacking In Jin Medical International Ltd. (NASDAQ:ZJYL) As Shares Slide 31%

Sep 07
Some Confidence Is Lacking In Jin Medical International Ltd. (NASDAQ:ZJYL) As Shares Slide 31%

Jin Medical International (NASDAQ:ZJYL) Seems To Use Debt Quite Sensibly

Aug 24
Jin Medical International (NASDAQ:ZJYL) Seems To Use Debt Quite Sensibly

Revenues Not Telling The Story For Jin Medical International Ltd. (NASDAQ:ZJYL) After Shares Rise 25%

Jul 24
Revenues Not Telling The Story For Jin Medical International Ltd. (NASDAQ:ZJYL) After Shares Rise 25%

Capital Allocation Trends At Jin Medical International (NASDAQ:ZJYL) Aren't Ideal

Jul 17
Capital Allocation Trends At Jin Medical International (NASDAQ:ZJYL) Aren't Ideal

Jin Medical International Ltd. (NASDAQ:ZJYL) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Jun 04
Jin Medical International Ltd. (NASDAQ:ZJYL) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Jin Medical International Ltd.'s (NASDAQ:ZJYL) Shares Climb 372% But Its Business Is Yet to Catch Up

Dec 27
Jin Medical International Ltd.'s (NASDAQ:ZJYL) Shares Climb 372% But Its Business Is Yet to Catch Up

What Jin Medical International Ltd.'s (NASDAQ:ZJYL) 69% Share Price Gain Is Not Telling You

Sep 29
What Jin Medical International Ltd.'s (NASDAQ:ZJYL) 69% Share Price Gain Is Not Telling You

CEO Compensation Analysis

How has Erqi Wang's remuneration changed compared to Jin Medical International's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

US$3m

Dec 31 2023n/an/a

US$3m

Sep 30 2023US$126kUS$126k

US$3m

Jun 30 2023n/an/a

US$3m

Mar 31 2023n/an/a

US$3m

Dec 31 2022n/an/a

US$3m

Sep 30 2022US$107kUS$107k

US$3m

Jun 30 2022n/an/a

US$2m

Mar 31 2022n/an/a

US$2m

Dec 31 2021n/an/a

US$2m

Sep 30 2021US$63kUS$63k

US$3m

Jun 30 2021n/an/a

US$3m

Mar 31 2021n/an/a

US$3m

Dec 31 2020n/an/a

US$3m

Sep 30 2020US$79kUS$52k

US$2m

Compensation vs Market: Erqi's total compensation ($USD126.36K) is below average for companies of similar size in the US market ($USD1.46M).

Compensation vs Earnings: Erqi's compensation has been consistent with company performance over the past year.


CEO

Erqi Wang (54 yo)

4.8yrs

Tenure

US$126,364

Compensation

Mr. Erqi Wang has been the Chief Executive Officer and Chairman of the board of Jin Medical International Ltd. since January 2020, and serves as its President. He has served as CEO and Chairman of Changzho...


Board Members

NamePositionTenureCompensationOwnership
Erqi Wang
Chairman of the Board4.8yrsUS$126.36kno data
Ziqiang Wang
CFO & Director2.9yrsUS$41.17kno data
Oliver St. Franklin
Independent Directorno datano datano data
Yanru Guo
Independent Directorless than a yearno datano data
Jourdan Frain
Independent Directorno datano datano data

2.9yrs

Average Tenure

53yo

Average Age

Experienced Board: ZJYL's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.